FIELD: medicine.
SUBSTANCE: what is administered is a combined therapeutic agent containing an activated potentiated form of human gamma-interferon (IFN-γ) antibodies, an activated potentiated form of CD4 receptor antibodies and an activated potentiated form of histamine antibodies.
EFFECT: effective treatment of the various types of influenza ensured by potentiating the antiviral activity of the activated potentiated gamma-interferon antibodies.
12 cl, 5 tbl, 1 dwg, 4 ex
Authors
Dates
2014-01-27—Published
2010-08-06—Filed